COX-2 inhibitors act as radiosensitizer in tumor treatment

Biomedicine and Pharmacotherapy

Volumn 59, Issue SUPPL. 2, 2005, Pages

  Sminia, P ^a   Kuipers, G ^a   Geldof, A ^a   Lafleur, V ^a   Slotman, B ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Brain tumor; COX 2 inhibition; Radiosensitization

Indexed keywords

4 [5 (4 CHLOROPHENYL) 3 TRIFLUOROMETHYL 1H PYRAZOL 1 YL]BENZENESULFONAMIDE; ACETYLSALICYLIC ACID; CELECOXIB; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; IBUPROFEN; INDOMETACIN; L 743337; MELOXICAM; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; RADIOSENSITIZING AGENT; ROFECOXIB; TEMOZOLOMIDE; THALIDOMIDE; UNCLASSIFIED DRUG;

ANGIOGENESIS; ARTICLE; BRAIN TUMOR; CANCER RADIOTHERAPY; CELL PROLIFERATION; CLINICAL TRIAL; ENZYME INHIBITION; GASTROINTESTINAL SYMPTOM; GLIOBLASTOMA; GLIOMA; HUMAN; IN VITRO STUDY; IN VIVO STUDY; IRRADIATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIOSENSITIZATION; TREATMENT OUTCOME; TUMOR CELL;

ANIMALS; BRAIN NEOPLASMS; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; HUMANS; NEOPLASMS; RADIATION-SENSITIZING AGENTS;

EID: 27144462431     PISSN: 07533322     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0753-3322(05)80044-7     Document Type: Article

References (29)

1. Brain Tumor Committee Int J Radiat Oncol Biol Phys 51 2001 11 18
2. Choy H., and Milas L. Enhancing radiotherapy with cyclooxygenase-2 enzyme inhibitors: a rational advance? J Natl Cancer Inst 95 2003 1440 1452
3. Davis T.W., O'Neal J.M., Pagel M.D., Zweifel B.S., Mehta P.P., and Heuvelman D.M. Synergy between celecoxib and radiotherapy results from inhibition of cyclooxygenase-2-derived prostaglandin E2, a survival factor for tumor and associated vasculature Cancer Res 64 2004 279 285
4. Deininger M.H., Weller M., Streffer J., Mittelbronn M., and Meyermann R. Patterns of cyclooxygenase-1 and -2 expression in human gliomas in vivo Acta Neuropathol 98 1999 240 244
5. Dicker A.P., Williams T.L., and Grant D.S. Targeting angiogenic processes by combination rofecoxib and ionizing radiation Am J Clin Oncol 24 2001 438 442
6. Gallo O., Franchi A., Magnelli L., Sardi I., Vannacci A., and Boddi V. Cyclooxygenase-2 pathway correlates with VEGF expression in head and neck cancer. Implications for tumor angiogenesis and metastasis Neoplasia 3 2001 53 61
7. Hoozemans J., Veerhuis R., Janssen I., Van Elk E.J., Rozemuller A.J., and Eikelenboom P. The role of cyclooxygenase 1 and 2 activity in prostaglandin E(2) secretion by cultured human adult microglia: Implications for Alzheimer's disease Brain Res 951 2002 218 226
8. Hulshof M.C., Koot R.W., Schimmel E.C., Dekker F., Bosch D.A., and Gonzalez Gonzalez D. Prognostic factors in glioblastoma multiforme. Ten years experience of a single institution Strahlenther Onkol 177 2001 283 290
9. Hulshof M.C.C.M. Modification of radiation effects in patients with glioblastoma multiforme Doctoral thesis 2002 University of Amsterdam Amsterdam, The Netherlands
10. Joki T., Heese O., Nikas D.C., Bello L., Zhang J., and Kraeft S.K. Expression of cyclooxygenase 2 (COX-2) in human glioma and in vitro inhibition by a specific COX-2 inhibitor, NS-398 Cancer Res 60 2000 4926 4931
11. Khuri F.R., Wu H., Lee J.J., Kemp B.L., Lotan R., and Lippman S.M. Cyclooxygenase-2 overexpression is a marker of poor prognosis in stage I non-small cell lung cancer Clin Cancer Res 7 2001 861 867
12. Kim G.E., Kim Y.B., Cho N.H., Chung H.C., Pyo H.R., and Lee J.D. Synchronous coexpression of epidermal growth factor receptor and cyclooxygenase-2 in carcinomas of the uterine cervix: a potential predictor of poor survival Clin Cancer Res 10 2004 1366 1374
13. Kishi K., Petersen S., Petersen C., Hunter N., Mason K., and Masferrer J.L. Preferential enhancement of tumor radioresponse by a cyclooxygenase-2 inhibitor Cancer Res 60 2000 1326 1331
14. Kuipers G.K., Sminia P., Wessel R.H., Stoter T.R., Hoozemans J.J., and Veldman B. The role of cyclooxygenase-2 (COX-2) and COX-2 modulation in radiosensitization of human malignant glioma Int J Radiat Oncol Biol Phys 55 2003 546/240
15. Kulkarni S.K., Jain N.K., and Singh A. Cyclooxygenase isoenzymes and newer therapeutic potential for selective COX-2 inhibitors Methods Find Exp Clin Pharmacol 22 2000 291 298
16. Masferrer J.L., Leahy K.M., Koki A.T., Zweifel B.S., Settle S.L., and Woerner B.M. Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors Cancer Res 60 2000 1306 1311
17. Masferrer J. Approach to angiogenesis inhibition based on cyclooxygenase-2. Review Cancer J 7 Suppl 3 2001 S144 S150
18. Milas L. Cyclooxygenase-2 (COX-2) enzyme inhibitors as potential enhancers of tumour radioresponse Semin Radiat Oncol 11 2001 290 299
19. Nam D.H., Park K., Park C., Im Y.H., Kim M.H., and Lee S. Intracranial inhibition of glioma cell growth by cyclooxygenase-2 inhibitor celecoxib Oncol Rep 1 2004 263 268
20. New P. Cyclooxygenase in the treatment of glioma: its complex role in signal transduction Cancer Control 11 2004 152 164
21. Pannullo S., Hariharan S., Serventi J., Hayes R., Balmaceda J., and Burton J. Phase I/II trial of a twice-daily regimen of temozolomide and celecoxib for treatment of relapsed/refractory glioblastoma multiforme and anaplastic astrocytoma J Clin Oncol 22 2004 14S/1549
22. Petersen C., Petersen S., Milas L., Lang F.F., and Tofilon P.J. Enhancement of intrinsic tumor cell radiosensitivity induced by a selective cyclooxygenase-2 inhibitor Clin Cancer Res 6 2000 2513 2520
23. Pyo H., Choy H., Amorino G.P., Kim J., Cao Q., and Hercules S.K. A selective cyclooxygenase-2 inhibitor, NS-398, enhances the effect of radiation in vitro and in vivo preferentially on the cells that express cyclooxygenase-2 Clin Cancer Res 7 2001 2998 3005
24. Raju U., Nakata E., Yang P., Newman R.A., Ang K.K., and Milas L. In vitro enhancement of tumor cell radiosensitivity by a selective inhibitor of cyclooxygenase-2 enzyme: mechanistic considerations Int J Radiat Oncol Biol Phys 54 2002 886 894
25. Ristimaki A., Sivula A., Lundin J., Lundin M., Salminen T., and Haglund C. Prognostic significance of elevated cyclooxygenase-2 expression in breast cancer Cancer Res 62 2002 632 635
26. Shono T., Tofilon P.J., Bruner J.M., Owolabi O., and Lang F.F. Cyclooxygenase-2 expression in human gliomas: prognostic significance and molecular correlations Cancer Res 61 2001 4375 4381
27. Slotman B.J., Kralendonk J.H., Van Alphen H.A., Kamphorst W., and Karim A.B. Hypofractionated radiation therapy in patients with glioblastoma multiforme: results of treatment and impact of prognostic factors Int J Radiat Oncol Biol Phys 34 1996 895 898
28. Sminia P., Stoter T.R., Van der Valk P., Van Nifterik K.A., Tadema T.M., and Hulsebos T.I.M. Cyclooxygenase-2 expression in human gliomas Radiother Oncol 67 Suppl 1 2003 S24 S72
29. Turini M.E., and DuBois R.N. Cyclooxygenase-2: a therapeutic target Annu Rev Med 53 2002 35 57